×

Chemically modified small molecules

  • US 20060182692A1
  • Filed: 01/30/2006
  • Published: 08/17/2006
  • Est. Priority Date: 12/16/2003
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of modifying the rate of systemic absorption of a drug administered to a subject by a pulmonary route, the method comprising covalently conjugating a hydrophilic polymer to a drug, wherein the drug has a half-life of elimination from the lung of less than about 180 minutes, to form a drug-polymer conjugate, wherein the drug-polymer conjugate has a net hydrophilic character and a weight average molecular weight of from about 50 to about 20,000 Daltons, and wherein the half-life of elimination from the lung of the drug-polymer conjugate is at least about 1.5-fold greater than the half-life of elimination from the lung of the drug, wherein the half-life of elimination from the lung is measured by bronchoalveolar lavage followed by assaying residual lung material.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×